Auddia increases bridge funding limits for merger target companies

Auddia Inc., a privately held company with a market cap of $5.43 million, announced on October 16 that it had raised the maximum funding limits under bridge notes for four of its target companies. These companies—Thramann Holdings, LT350, Influence Healthcare, and Voyex—are all controlled by Thramann Holdings and are set to become subsidiaries of Auddia's parent company, McCarthy Finney, upon the completion of a pending merger.

The maximum funding limits were increased to $420,000 for Thramann Holdings, $1,900,000 for LT350, $900,000 for Influence Healthcare, and $85,000 for Voyex. Previously, the limits were $360,000, $400,000, $590,000, and $50,000 respectively. The funding is provided in tranches, with any advance over $50,000 requiring approval from Auddia's Audit Committee.

The bridge notes underwent review and approval by Auddia's special committee of independent and disinterested directors, as well as the Audit Committee. The closing of the merger is contingent upon certain conditions, including approval by Auddia's stockholders.